Neurotoxicity of antineoplastic agents
- 28 February 1993
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 14 (1) , 61-75
- https://doi.org/10.1016/1040-8428(93)90006-p
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Peripheral neuropathy and ototoxicity of dichlorodiamineplatinum: Instrumental evaluationGynecologic Oncology, 1986
- Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanomaCancer, 1984
- Human leukocyte interferon (HuIFN-α): Potent endorphin-like opioid activityBiochemical and Biophysical Research Communications, 1981
- Block of axoplasmic transport in vitro by vinca alkaloidsJournal of Neurobiology, 1980
- Thiourea Reverses Cross-Links and Restores Biological Activity in DNA Treated with Dichlorodiaminoplatinum(II)Science, 1979
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975
- Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level)The Journal of Pediatrics, 1972